IMRT is a new treatment method for nasopharyngeal cancer that has the potential to improve local control, especially for T3 and T4 tumors, reduce post-irradiation complications, and reduce the rate of distant metastasis. A study of 13 NPC patients treated with IMRT found that it resulted in reduced acute reactions and improved dosimetry compared to conventional radiotherapy. Further research is needed to optimize target definition and dose distribution in IMRT for NPC.